These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 29490279)

  • 1. USP2a Supports Metastasis by Tuning TGF-β Signaling.
    Zhao Y; Wang X; Wang Q; Deng Y; Li K; Zhang M; Zhang Q; Zhou J; Wang HY; Bai P; Ren Y; Zhang N; Li W; Cheng Y; Xiao W; Du HN; Cheng X; Yin L; Fu X; Lin D; Zhou Q; Zhong B
    Cell Rep; 2018 Feb; 22(9):2442-2454. PubMed ID: 29490279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGFBR2 mediated phosphorylation of BUB1 at Ser-318 is required for transforming growth factor-β signaling.
    Nyati S; Gregg BS; Xu J; Young G; Kimmel L; Nyati MK; Ray D; Speers C; Rehemtulla A
    Neoplasia; 2020 Apr; 22(4):163-178. PubMed ID: 32143140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ubiquitin-specific protease 4 promotes metastasis of hepatocellular carcinoma by increasing TGF-β signaling-induced epithelial-mesenchymal transition.
    Qiu C; Liu Y; Mei Y; Zou M; Zhao Z; Ye M; Wu X
    Aging (Albany NY); 2018 Oct; 10(10):2783-2799. PubMed ID: 30335615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liebig's law of the minimum in the TGF-β/SMAD pathway.
    Li Y; Deng D; Höfer CT; Kim J; Do Heo W; Xu Q; Liu X; Zi Z
    PLoS Comput Biol; 2024 May; 20(5):e1012072. PubMed ID: 38753874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional similarity between TGF-beta type 2 and type 1 receptors in the female reproductive tract.
    Ni N; Fang X; Li Q
    Sci Rep; 2021 Apr; 11(1):9294. PubMed ID: 33927274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linc00462 promotes pancreatic cancer invasiveness through the miR-665/TGFBR1-TGFBR2/SMAD2/3 pathway.
    Zhou B; Guo W; Sun C; Zhang B; Zheng F
    Cell Death Dis; 2018 Jun; 9(6):706. PubMed ID: 29899418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NSD2 inhibition suppresses metastasis in cervical cancer by promoting TGF-β/TGF-βRI/SMADs signaling.
    Zhu L; Yu CL; Zheng Y
    Biochem Biophys Res Commun; 2019 Nov; 519(3):489-496. PubMed ID: 31526565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mesenchymal-like subpopulation in non-neuroendocrine SCLC contributes to metastasis.
    Jin Y; Xiao T; Feng Y; Yang J; Guo C; Hu L; Ji H
    J Genet Genomics; 2021 Jul; 48(7):571-581. PubMed ID: 34373217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ras enhances TGF-β signaling by decreasing cellular protein levels of its type II receptor negative regulator SPSB1.
    Liu S; Iaria J; Simpson RJ; Zhu HJ
    Cell Commun Signal; 2018 Mar; 16(1):10. PubMed ID: 29534718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of TGF-β receptor I expression in a DNA methylation-independent manner mediated by DNMT3A downregulation is involved in early-onset severe preeclampsia.
    Jia Y; Xie H; Zhang J; Ying H
    FASEB J; 2020 Oct; 34(10):13224-13238. PubMed ID: 32794622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD109-mediated degradation of TGF-β receptors and inhibition of TGF-β responses involve regulation of SMAD7 and Smurf2 localization and function.
    Bizet AA; Tran-Khanh N; Saksena A; Liu K; Buschmann MD; Philip A
    J Cell Biochem; 2012 Jan; 113(1):238-46. PubMed ID: 21898545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRAF4 promotes TGF-β receptor signaling and drives breast cancer metastasis.
    Zhang L; Zhou F; García de Vinuesa A; de Kruijf EM; Mesker WE; Hui L; Drabsch Y; Li Y; Bauer A; Rousseau A; Sheppard KA; Mickanin C; Kuppen PJ; Lu CX; Ten Dijke P
    Mol Cell; 2013 Sep; 51(5):559-72. PubMed ID: 23973329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HSP70 decreases receptor-dependent phosphorylation of Smad2 and blocks TGF-β-induced epithelial-mesenchymal transition.
    Li Y; Kang X; Wang Q
    J Genet Genomics; 2011 Mar; 38(3):111-6. PubMed ID: 21477782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Akt/PKB-mediated phosphorylation of Twist1 promotes tumor metastasis via mediating cross-talk between PI3K/Akt and TGF-β signaling axes.
    Xue G; Restuccia DF; Lan Q; Hynx D; Dirnhofer S; Hess D; Rüegg C; Hemmings BA
    Cancer Discov; 2012 Mar; 2(3):248-59. PubMed ID: 22585995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-beta- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis.
    Rosendahl A; Speletas M; Leandersson K; Ivars F; Sideras P
    Int Immunol; 2003 Dec; 15(12):1401-14. PubMed ID: 14645149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-β and epithelial-mesenchymal transition are associated with pulmonary metastasis in adenoid cystic carcinoma.
    Dong L; Ge XY; Wang YX; Yang LQ; Li SL; Yu GY; Gao Y; Fu J
    Oral Oncol; 2013 Nov; 49(11):1051-8. PubMed ID: 23962790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of transforming growth factor-beta1-induced signaling and epithelial-to-mesenchymal transition by the Smad-binding peptide aptamer Trx-SARA.
    Zhao BM; Hoffmann FM
    Mol Biol Cell; 2006 Sep; 17(9):3819-31. PubMed ID: 16775010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ubiquitin-Specific Protease 15 Maintains Transforming Growth Factor-β Pathway Activity by Deubiquitinating Transforming Growth Factor-β Receptor I during Wound Healing.
    Zhao Y; Wang Z; Ho C; Zhang G; Li Q
    Am J Pathol; 2019 Jul; 189(7):1351-1362. PubMed ID: 30980801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smad2/3/4 Pathway Contributes to TGF-β-Induced MiRNA-181b Expression to Promote Gastric Cancer Metastasis by Targeting Timp3.
    Zhou Q; Zheng X; Chen L; Xu B; Yang X; Jiang J; Wu C
    Cell Physiol Biochem; 2016; 39(2):453-66. PubMed ID: 27383203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. POH1 contributes to hyperactivation of TGF-β signaling and facilitates hepatocellular carcinoma metastasis through deubiquitinating TGF-β receptors and caveolin-1.
    Wang B; Xu X; Yang Z; Zhang L; Liu Y; Ma A; Xu G; Tang M; Jing T; Wu L; Liu Y
    EBioMedicine; 2019 Mar; 41():320-332. PubMed ID: 30745168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.